Literature DB >> 19885829

Oxidative stress up-regulates presenilin 1 in lipid rafts in neuronal cells.

Akiko Oda1, Akira Tamaoka, Wataru Araki.   

Abstract

Oxidative stress is associated with beta-amyloid peptide (A beta) accumulation in the brains of Alzheimer's disease patients. A beta is generated upon the sequential proteolytic cleavage of transmembrane amyloid precursor protein (APP) by two membrane-bound proteases, beta-secretase (BACE1) and the gamma-secretase complex comprising presenilin 1 (PS1), nicastrin, APH-1 and PEN-2. Recent evidence suggests that significant amounts of BACE1 and gamma-secretase components localize in the cholesterol-rich region of membranes known as lipid rafts, where A beta production occurs preferentially. In this study, we investigated the effects of oxidative stress on the BACE1 and gamma-secretase components in lipid rafts using human neuroblastoma SH-SY5Y cells exposed to ethacrynic acid (EA), a compound that induces cellular glutathione depletion. Following exposure of cells to EA, heme oxygenase-1, a marker protein of oxidative stress, was strongly induced. Moreover, treatment with EA resulted in a significant increase in PS1 protein levels, but not those of nicastrin, APH-1, PEN-2 or BACE1, in both cell lysates and the lipid raft fraction. This increase in PS1 protein expression was prevented by co-treatment with an antioxidant, N-acetylcysteine (NAC). EA additionally induced a significant increase in PS1 mRNA expression, which was inhibited by NAC. Finally, EA treatment was found to promote A beta secretion from cells expressing Swedish mutant APP. It appears that in our cell culture model, oxidative stress enhances PS1 protein levels in lipid rafts via up-regulation of PS1 transcription, which may constitute the mechanism underlying the oxidative stress-associated promotion of A beta production. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19885829     DOI: 10.1002/jnr.22271

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  34 in total

Review 1.  The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune Disorders.

Authors:  Gerwyn Morris; Ken Walder; Basant K Puri; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

3.  Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.

Authors:  Liu He; Yuqi Jiang; Kai Liu; Victoria Gomez-Murcia; Xiaopin Ma; Alejandro Torrecillas; Qun Chen; Xiongwei Zhu; Edward Lesnefsky; Juan C Gomez-Fernandez; Bin Xu; Shijun Zhang
Journal:  J Med Chem       Date:  2018-01-05       Impact factor: 7.446

4.  γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.

Authors:  Xiaoping Qi; Jun Cai; Qing Ruan; Li Liu; Sanford L Boye; Zhijuan Chen; William W Hauswirth; Renee C Ryals; Lynn Shaw; Sergio Caballero; Maria B Grant; Michael E Boulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-01       Impact factor: 4.799

5.  Anti-amyloidgenic and neurotrophic effects of tetrahydroxystilbene glucoside on a chronic mitochondrial dysfunction rat model induced by sodium azide.

Authors:  Ru-Yi Zhang; Lan Zhang; Li Zhang; Yu-Lan Wang; Lin Li
Journal:  J Nat Med       Date:  2018-03-05       Impact factor: 2.343

6.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

7.  Citrulline diet supplementation improves specific age-related raft changes in wild-type rodent hippocampus.

Authors:  Perrine Marquet-de Rougé; Christine Clamagirand; Patricia Facchinetti; Christiane Rose; Françoise Sargueil; Chantal Guihenneuc-Jouyaux; Luc Cynober; Christophe Moinard; Bernadette Allinquant
Journal:  Age (Dordr)       Date:  2012-08-24

8.  PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Fang Du; Qing Yu; Shijun Yan; Gang Hu; Lih-Fen Lue; Douglas G Walker; Long Wu; Shi Fang Yan; Kim Tieu; Shirley ShiDu Yan
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

9.  Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons.

Authors:  Ai Hosaka; Wataru Araki; Akiko Oda; Yasushi Tomidokoro; Akira Tamaoka
Journal:  Neurochem Res       Date:  2012-12-28       Impact factor: 3.996

10.  Loss of Spatial Memory, Learning, and Motor Function During Normal Aging Is Accompanied by Changes in Brain Presenilin 1 and 2 Expression Levels.

Authors:  Simon Kaja; Nathalie Sumien; Vidhi V Shah; Imran Puthawala; Alexandra N Maynard; Nitasha Khullar; Andrew J Payne; Michael J Forster; Peter Koulen
Journal:  Mol Neurobiol       Date:  2014-09-10       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.